Physician profile
Timothy B Brown
NPI 1255392346
$7,380.01
in general payments reported to CMS, 2019-2025
22 companies · $445 in 2025
The $445 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,272 · 2020: $4,017 · 2021: $475 · 2022: $287 · 2023: $670 · 2024: $214 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,329.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,796.34 | 2020-2023 | |
| Medical Device Business Services, INC. | $1,013.88 | 2019 | |
| Daiichi Sankyo INC. | $937.16 | 2020-2025 | Injectafer |
| Abbvie INC. | $687.37 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $191.48 | 2023 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $134.65 | 2020-2025 | |
| Biogen, INC. | $130.01 | 2025 | Zurzuvae |
| Aspira Women'S Health INC | $88.55 | 2019-2024 | Ova1 |
| Pfizer INC. | $74.94 | 2023-2024 | |
| Becton, Dickinson and Company | $46.00 | 2023-2025 | Arista, Bd Onclarity |
| Hologic Sales and Service, LLC | $37.13 | 2023-2024 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Evofem Biosciences, INC. | $34.14 | 2021-2022 | |
| Exact Sciences Corporation | $31.88 | 2023-2025 | Cologuard Collection Kit |
| Organon LLC | $30.60 | 2025 | Nexplanon |
| Baxter Healthcare | $24.56 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $22.02 | 2025 | |
| Genzyme Corporation | $20.23 | 2024 | |
| Mayne Pharma Commercial LLC | $18.88 | 2025 | |
| Optumhealth Care Solutions, LLC | $17.48 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Merck Sharp & Dohme LLC | $14.87 | 2019 | |
| Boston Scientific Corporation | $14.24 | 2019 | |
| Exeltis, USA INC. | $13.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.